A recent technology is now available to visualize individual cells in the living eye. The split-detector adaptive optics scanning light ophthalmoscope (AOSLO)
3 is a noninvasive retinal imaging technique that corrects for optical distortions, allowing high-resolution images of the photoreceptor layer to be obtained in living patients
4 (see
Fig. 1). AOSLO has made it possible to view (and measure) retinal tissue in microscopic detail in a way that was previously only possible in postmortem patients. This has allowed the quantitative study of changes at the cellular level caused by various diseases.
5 Indeed, it has been used to describe the degeneration of photoreceptor structure in the retina by various quantitative measurements in several inherited retinal diseases, such as Stargardt’s disease and retinitis pigmentosa).
4,6,7 Retinitis pigmentosa is a group of eye diseases of genetic origin. It affects the photoreceptor cells of the retina (first the rods, and then the cones
8), causing first the loss of peripheral and night vision, which in fact is the first associated symptom.
2,9 However, the diagnosis of retinitis pigmentosa is difficult because there is no specific test and the actual diagnosis is made after various examinations, such as optical coherence tomography (OCT), angiography, electroretinography, and genetic testing. Therefore, by the time an accurate diagnosis is made, patients are at an advanced stage of the disease.
9 Stargardt's is also a genetic disease that affects vision in the macula and can lead to complete loss of central vision.
10 It does not cause complete loss of vision because patients retain peripheral vision. Stargardt's disease is generally diagnosed between the ages of 10 and 20 years, but, like retinitis pigmentosa, the diagnosis process is not straightforward and involves a number of different tests.
11